Cardiff Researcher awarded Future Leaders Fellowship from Brain Tumour Charity

The Fellowship supports clinical and scientific research in the brain tumour field, and is intended for earlier stage research that promises to improve the lives of patients and their families.

Glioblastoma (GBM) is a particularly aggressive form of cancer that is currently terminal in all cases. GBM accounts for half of all cancerous brain tumours in adults.

Dr Clement’s research aims to transform current knowledge about treating GBM by understanding more about the potential of manipulating the immune system.

By understanding T-Cell responses, which play a major role in how the immune system responds to tumours, Dr Clement hopes to enable the development of new treatments.

Dr Clement’s background is in immune responses to chronic viral infections, enabling him to apply an interdisciplinary approach to his research.

Speaking about the fellowship, Dr Clement said “This award will allow me to make key step-changes in our understanding of the interface between the immune system and the brain. This prestigious award supports excellent academic researchers funding scientific research into brain tumours. This award can be extended over 12 years providing up to £1.8m funding to support my research allowing me to establish myself as a leading brain cancer researcher. This is the first time this award has been granted to anyone in Wales.”